# Lunit vs Prolific

Lunit records 29,181 monthly visits with -12.8% month-over-month growth and Contact for Pricing pricing. Prolific records 18,697,671 monthly visits with -1.8% growth and Paid pricing.

| Metric | [Lunit](https://openaitools.app/tool/lunit) | [Prolific](https://openaitools.app/tool/prolific-com) |
| :--- | :--- | :--- |
| Website URL | https://www.lunit.io/en | https://prolific.com |
| Categories | AI Healthcare, AI Medical Diagnosis, AI Image Recognition | AI Research Tool, AI Developer Tools, AI For Data Analytics |
| Pricing Model | Contact for Pricing | Paid |
| Monthly Visits | 29,181 | 18,697,671 |
| MoM Growth Rate | -12.8% | -1.8% |
| Primary Market | South Korea | United States |
| Direct Visits | 8,314 | 12,979,710 |
| Review Score | 4.6 | 4.6 |
| Saved Count | 1 | 13 |
| Supported Platforms | Website | Website |

## Lunit

Lunit is a medical AI company headquartered in Seoul, South Korea, spun out of deep-learning research and focused squarely on oncology. Rather than chasing general-purpose healthcare AI, it has built two connected product families: one that helps clinicians find cancer earlier in imaging, and one that extracts quantitative biology from tissue to guide treatment and drug development. Its technology is used across a large international footprint spanning more than 10,000 customer sites in over 70 countries, with hundreds of peer-reviewed publications and industry partnerships behind the deployments.

On the screening side, the Lunit INSIGHT family analyzes mammograms and chest radiographs. Lunit INSIGHT MMG handles 2D mammography while Lunit INSIGHT DBT covers 3D breast tomosynthesis, both designed to flag suspicious regions so radiologists can prioritize the studies that need attention most. Lunit INSIGHT CXR does the same for chest X-rays. Around these detection engines Lunit has assembled program-level tooling: density assessment, risk assessment and risk pathways, live mammography reporting, quality management, analytics, and a patient hub, so a screening service can run AI as part of its routine rather than as an isolated experiment.

On the precision oncology side, the Lunit SCOPE portfolio analyzes pathology images. Lunit SCOPE IO quantifies the tumor microenvironment and immune cell infiltration, which matters for immunotherapy strategy, while the Lunit SCOPE IHC Suite supports immunohistochemistry quantification across markers such as HER2 and PD-L1, alongside a genotype prediction tool. These products are aimed at biopharma partners, clinical trial teams, and companion diagnostic development, where reproducible quantitative readouts are the bottleneck. Because Lunit sells to hospitals, screening programs, and pharmaceutical companies, pricing is quoted directly rather than published, and regulatory status differs by market.

**Pricing & Plans:** Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

- **Lunit INSIGHT MMG and DBT:** Deep-learning analysis of 2D and 3D mammography that marks suspicious lesions to help radiologists detect breast cancer earlier and reduce missed findings.
- **Lunit INSIGHT CXR:** Chest X-ray analysis that highlights potential abnormalities such as nodules and other findings, supporting faster triage in high-volume radiology workflows.
- **Lunit SCOPE IO:** Tumor microenvironment analysis that quantifies tumor-infiltrating lymphocytes and immune phenotypes from pathology slides, informing immunotherapy research.
- **Lunit SCOPE IHC Suite:** AI-assisted immunohistochemistry quantification covering HER2, PD-L1, and other markers, including uIHC and a gene-expression prediction tool for standardized scoring.
- **Screening analytics and workflow tools:** Live mammography reporting, risk assessment, risk pathways, quality management, and patient-facing tools that embed AI into the wider screening program.

**Strengths:** Clinically validated radiology AI with documented regulatory clearances and published evidence; Covers two ends of the cancer pathway — screening detection and precision oncology biomarkers — in one vendor relationship; Wide real-world adoption across many countries, which means integrations and workflow lessons already exist; Strong research output and biopharma partnerships support credibility for trial and CDx work

[Profile (Markdown)](https://openaitools.app/tool/lunit.md)

## Prolific

Prolific operates a marketplace where researchers and organisations post studies and verified participants complete them for payment. The pitch is quality over volume: instead of a massive but unvetted panel, Prolific verifies participants, applies attention and honesty checks, and lets requesters filter by detailed demographic, professional, and behavioural criteria. That makes it possible to target narrow, representative groups — for example coding experts, healthcare professionals, or specific national populations — which matters when a study compares groups or needs to generalise beyond a convenience sample.

In recent years Prolific has leaned heavily into AI. Its AI offering covers human preference data for fine-tuning and reinforcement learning, safety evaluation, red-teaming, and benchmarks across languages and tasks. It also publishes a leaderboard of model quality based on human evaluation, and offers developer-facing tooling such as a human-feedback API, agent workflows, and a Model Context Protocol server so AI pipelines can call for human input programmatically. Alongside this, the original academic and market-research business remains central.

Pricing is usage-based. Requesters pay for participant rewards plus a platform fee, and researchers either fund studies per response or talk to sales for larger programmes and managed services. Because rates depend on study length, targeting criteria, and volumes, published list prices are rare — the platform directs larger customers to a sales conversation.

**Pricing & Plans:** Usage-based for requesters: you pay participant rewards plus a platform fee, with custom quotes for large or managed programmes. Participants earn per completed study; joining is free.

- **Verified, targetable participant pool:** Filter participants by detailed demographic, professional, and behavioural criteria and reach narrow or representative samples rather than a generic crowd.
- **AI data and human feedback:** Collect human preference data for model fine-tuning, run safety evaluations and red-teaming, and use a feedback API to plug humans into automated pipelines.
- **Built-in data-quality controls:** Attention checks, honesty screening, and approval workflows help filter out careless or fraudulent responses before you analyse results.
- **Fast study launches:** Publish a study and begin collecting responses quickly, with tooling that supports screening, quotas, and longitudinal designs.
- **Participant side with guaranteed pay:** Participants get a clear per-study reward, flexible scheduling, and a minimum pay standard enforced by the platform.

**Strengths:** Strong focus on data quality with verification and attention checks; Granular targeting that supports niche and representative samples; Fast turnaround compared with traditional panel providers; Growing AI-focused tooling including a human-feedback API and MCP server

**Limitations:** Pricing is quote-based for many use cases, which makes budgeting less transparent up front; Participant availability in some narrow demographics can be limited or slower to fill; Costs add up quickly for large multi-country or longitudinal studies

[Profile (Markdown)](https://openaitools.app/tool/prolific-com.md)

## Frequently Asked Questions

### How do Lunit and Prolific compare in monthly traffic?

Lunit has 29,181 monthly visits, while Prolific has 18,697,671. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Lunit has a month-over-month growth rate of -12.8%; Prolific has -1.8%.

### How does pricing compare?

Lunit: Contact for Pricing. Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered. Prolific: Paid. Usage-based for requesters: you pay participant rewards plus a platform fee, with custom quotes for large or managed programmes. Participants earn per completed study; joining is free.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Branded](https://openaitools.app/tool/gobranded-com) | 3,704,728 | +6.6% | Contact for Pricing | Large consumer panel for market research surveys, but lacks Prolific's specialized focus on academic studies and AI tuning. | [.md](https://openaitools.app/tool/gobranded-com.md) |
| 2 | [Labelbox](https://openaitools.app/tool/labelbox) | 762,803 | -22.8% | Contact for Pricing | The environments frontier AI trains on, and the agents that do the recurring work | [.md](https://openaitools.app/tool/labelbox.md) |
| 3 | [Appen](https://openaitools.app/tool/appen-com) | 665,840 | +0.2% | Contact for Pricing | Enterprise-grade data annotation and AI alignment workforce, but less self-serve for academic study recruitment and casual surveys. | [.md](https://openaitools.app/tool/appen-com.md) |
| 4 | [SuperAnnotate](https://openaitools.app/tool/super-annotate) | 386,034 | +37.4% | Free Trial, Contact for Pricing | AI data infrastructure for building production-grade models | [.md](https://openaitools.app/tool/super-annotate.md) |
| 5 | [Voxpopme](https://openaitools.app/tool/voxpopme-com) | 301,522 | +38.5% | Contact for Pricing | Specializes in video-based consumer interviews and AI qualitative analysis, but less focused on quantitative academic survey panels. | [.md](https://openaitools.app/tool/voxpopme-com.md) |
| 6 | [Emporia Research](https://openaitools.app/tool/emporia-research) | 270,281 | -0.6% | Contact for Pricing | Sources verified B2B professionals and healthcare experts for specialized research, but lacks broad general-population academic panels. | [.md](https://openaitools.app/tool/emporia-research.md) |
| 7 | [ScanSkinAI](https://openaitools.app/tool/scanskinai) | 265,770 | -10.9% | Freemium, Paid | Free AI skin and mole scanning with optional dermatologist review | [.md](https://openaitools.app/tool/scanskinai.md) |
| 8 | [Overjet](https://openaitools.app/tool/overjet-ai) | 256,150 | +12.6% | Contact for Pricing | FDA-cleared dental AI for diagnostics, imaging, and insurance workflow | [.md](https://openaitools.app/tool/overjet-ai.md) |
| 9 | [Pearl](https://openaitools.app/tool/hellopearl-com) | 221,155 | -7.6% | Contact for Pricing | FDA-cleared dental AI for sharper diagnosis and a smoother front office | [.md](https://openaitools.app/tool/hellopearl-com.md) |
| 10 | [Label Studio](https://openaitools.app/tool/label-studio) | 137,199 | -16.1% | Contact for Pricing, Free | Open-source data labeling and evaluation platform for AI workflows, but requires bringing your own annotation workforce. | [.md](https://openaitools.app/tool/label-studio.md) |

---
Source: https://openaitools.app/compare/lunit-vs-prolific-com

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)